Viemed Healthcare, Inc. (VMD): A Bull Case Theory
We came across a bullish thesis on Viemed Healthcare, Inc. (VMD) on Substack by Petty Cash. In this article, we will summarize the bulls’ thesis on VMD. Viemed Healthcare, Inc.
Viemed Healthcare Inc. (VMD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 935,122 | $7,499,678 | -18% | 0.32% |
| 2. | Divisadero Street Capital William Zolezzi | 646,273 | $5,183,109 | +85% | 0.6% |
| 3. | Renaissance Technologies Jim Simons | 373,000 | $2,991,460 | +3% | 0% |
| 4. | First Eagle Investment Management Jean-Marie Eveillard | 328,824 | $2,637,168 | +197% | 0% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 193,096 | $1,548,630 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.10 | 2,000 | Director | 41,040 | 2024-05-14 | Filing | |
| $7.07 | 485 | Director | 39,040 | 2024-05-14 | Filing | |
| $7.01 | 335 | Director | 38,555 | 2024-05-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.58 | 5,995 | Director | 126,843 | 2024-11-26 | Filing | |
| $8.70 | 24,005 | Director | 126,843 | 2024-11-25 | Filing | |
| $8.50 | 15,000 | Director | 126,843 | 2024-11-20 | Filing | |
| $8.56 | 15,000 | Director | 126,843 | 2024-11-19 | Filing | |
| $9.28 | 36,261 | Director | 107,706 | 2024-11-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,088,818 | $24,772,321 | 0% | |
| 2. | 1,792,235 | $14,373,724 | 0% | |
| 3. | 1,717,498 | $13,774,334 | 5.76% | |
| 4. | 1,327,688 | $10,648,058 | 0.05% | |
| 5. | 1,300,000 | $10,426,000 | 4.4% |
News See All
Viemed Healthcare, Inc. (NASDAQ:VMD) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to Viemed's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Viemed Healthcare, Inc. (NASDAQ:VMD) Q2 2024 Earnings Call Transcript
Operator: Good day ladies and gentlemen and welcome to the Viemed Second Quarter 2024 Earnings Call. Our host for today's call is Todd Zehnder, Chief Operating Officer.
Viemed Healthcare, Inc. (NASDAQ:VMD) Q1 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Viemed First Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Viemed Healthcare, Inc. (NASDAQ:VMD) Q4 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Viemed Fourth Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Should You Hold Viemed Healthcare (VMD)?
Wasatch Global Investors, an investment management firm, released its “Wasatch Micro Cap Value Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Viemed Healthcare, Inc. (NASDAQ:VMD) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to Viemed's 3Q 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Should You Hold Viemed Healthcare (VMD) for the Long-Term?
Investment management company Cove Street Capital recently released its “Small Cap Value Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Viemed Healthcare, Inc. (NASDAQ:VMD) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Viemed Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Viemed Healthcare (VMD) Executes on its Core Growth Strategy
Investment management company Cove Street Capital recently released its “Small Cap Value Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
